Clinical Trial Update: Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies [Phase 2]

View source ↗

Summary

Phase 2 trial results for VSJ-110 in adults with allergic conjunctivitis, reporting safety and efficacy data. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• VSJ-110

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2025-09-11